Search

Search Constraints

You searched for: Author/Creator Zhang, Alison Y.

Search Results

1. An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy. Issue 5 (4th December 2018)

2. ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration‐resistant prostate cancer treated with enzalutamide (ANZUP 1901). (6th July 2021)

3. Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP. Issue 8 (10th March 2022)